BVF PARTNERS L P/IL

Average Profitability
3.86%
Insider Buys Quantity
174
Insider Buys Sum
$401.08M
Insider Sells Quantity
52
Insider Sells Sum
$253.38M

Insider Activity of BVF PARTNERS L P/IL

According to the SEC Form 4 filings, BVF PARTNERS L P/IL, being in a position of

  1. 10 percent owner at Eledon Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 1927937 shares for $4.57M, and sold 0 shares,
    over all time since 2023-05-05, has bought 3906869 shares for $9.14M, and sold 0 shares.

The largest purchase of all time was on 2021-07-01 and amounted to 1088332 shares of Kymera Therapeutics, Inc. for $51.15M.

The largest sale of all time was on 2021-07-02 and amounted to 2186022 shares of Merus N.V. for $45.36M.

Biography of BVF PARTNERS L P/IL

No biography is available at this moment.

2024-05-09PurchaseEledon Pharmaceuticals, Inc.
ELDN
10 percent owner
1.93M
7.8677%
$2.37$4.57M+16.46%
2023-11-16PurchaseRepare Therapeutics Inc.
RPTX
10 percent owner
295,745
0.6815%
$5.38$1.59M-30.09%
2023-11-15PurchaseRepare Therapeutics Inc.
RPTX
10 percent owner
931,556
2.0265%
$5.00$4.66M-28.94%
2023-11-03PurchaseKymera Therapeutics, Inc.
KYMR
director
197,699
0.3518%
$14.07$2.78M+153.89%
2023-11-02PurchaseKymera Therapeutics, Inc.
KYMR
director
216,406
0.3771%
$11.64$2.52M+199.01%
2023-11-02PurchaseRepare Therapeutics Inc.
RPTX
10 percent owner
783,709
1.8363%
$3.60$2.82M+8.01%
2023-09-12PurchaseOlema Pharmaceuticals, Inc.
OLMA
1.51M
2.9937%
$9.84$14.82M+1.67%
2023-05-05PurchaseEledon Pharmaceuticals, Inc.
ELDN
10 percent owner
1.98M
11.9399%
$2.31$4.57M-41.42%
2023-01-12PurchaseKymera Therapeutics, Inc.
KYMR
director
18,897
0.0302%
$31.24$590,391-26.07%
2023-01-11PurchaseKymera Therapeutics, Inc.
KYMR
director
22,110
0.038%
$29.89$660,799-16.97%
2023-01-06PurchaseXOMA Corporation
XOMA
director
1,573
0.0137%
$21.98$34,577-19.69%
2023-01-06PurchaseXOMA Corporation
XOMA
director
3,249
0.0282%
$21.98$71,419-19.69%
2023-01-05PurchaseXOMA Corporation
XOMA
director
15,670
0.1152%
$18.39$288,096-18.64%
2023-01-05PurchaseXOMA Corporation
XOMA
director
19,000
0.1396%
$18.39$349,319-18.64%
2022-01-31PurchaseKymera Therapeutics, Inc.
KYMR
director
34,408
0.0646%
$40.70$1.4M-33.05%
2022-01-27PurchaseKymera Therapeutics, Inc.
KYMR
director
95,901
0.1917%
$38.33$3.68M-24.25%
2022-01-24PurchaseKymera Therapeutics, Inc.
KYMR
director
272,767
0.4999%
$37.76$10.3M-29.51%
2022-01-19PurchaseRepare Therapeutics Inc.
RPTX
10 percent owner
997,961
2.3789%
$14.10$14.07M-4.25%
2021-11-30PurchaseOlema Pharmaceuticals, Inc.
OLMA
739,675
1.9974%
$9.39$6.95M-52.69%
2021-10-08SaleMerus N.V.
MRUS
10 percent owner
147,267
0.3769%
$27.79$4.09M-9.47%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.